Review
doi: 10.1254/fpj.130.321.
[Ultiva (remifentanil hydrochloride), intravenous dose of 2mg, 5mg: pharmacological and clinical profile]
[Article in
Japanese]
- PMID: 17938519
- DOI: 10.1254/fpj.130.321
Item in Clipboard
Review
[Ultiva (remifentanil hydrochloride), intravenous dose of 2mg, 5mg: pharmacological and clinical profile]
[Article in
Japanese]
Nihon Yakurigaku Zasshi.
2007 Oct.
No abstract available
Similar articles
-
A girl of early school-age with no response to opioids during general anaesthesia.Tidsskr Nor Laegeforen. 2019 Mar 31;139(7). doi: 10.4045/tidsskr.18.0561. Print 2019 Apr 9. Tidsskr Nor Laegeforen. 2019. PMID: 30969062 English, Norwegian. No abstract available.
-
Remifentanil and other opioids.Handb Exp Pharmacol. 2008;(182):283-311. doi: 10.1007/978-3-540-74806-9_14. Handb Exp Pharmacol. 2008. PMID: 18175097 Review.
-
Intravenous anaesthesia: new drugs, new concepts, and clinical applications.Can J Anaesth. 1996 May;43(5 Pt 2):R142-54. doi: 10.1007/BF03011676. Can J Anaesth. 1996. PMID: 8706217 Review. English, French. No abstract available.
-
[Effect of remifentanil on intraoperative ECoG--a comparison with sevoflurane].Masui. 2010 Feb;59(2):188-92. Masui. 2010. PMID: 20169955 Japanese.
-
A multicentre, randomised, open-label, controlled trial evaluating equivalence of inhalational and intravenous anaesthesia during elective craniotomy.Eur J Anaesthesiol. 2012 Aug;29(8):371-9. doi: 10.1097/EJA.0b013e32835422db. Eur J Anaesthesiol. 2012. PMID: 22569025 Clinical Trial.
